|
Combined Targeted and Untargeted Strategy for Quantification of Amino Acids and Acylcarnitines in Clinically Relevant Biofluids and Tissue Lysates
Vera van der Velpen (1), Tony Teav (1), Héctor Gallart-Ayala (1), Florence Mehl (1,2), Clotilde Roux (3), Shing-Chi Liu (1), Beat Riederer (4,5), Hugues Henry (6) and Julijana Ivanisevic (1) (1) Metabolomics Platform, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland (2) Vital-IT – Swiss Institute of Bioinformatics, Lausanne, Switzerland. (3) Clinical Chemistry Service, Lausanne University Hospital, Lausanne, Switzerland (4) Proteomic Unit, Centre for Psychiatric Neuroscience, Department of Psychiatry, CHUV, Lausanne, Switzerland (5) Department of Fundamental Neurosciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland (6) Innovation and Development Laboratory, Clinical Chemistry Service, Lausanne University Hospital, Lausanne, Switzerland
Warning: Undefined variable $headshot in /var/www/html/view_abstract/view_abstract_in_program.php on line 704
| | Vera van der Velpen (Presenter)  Metabolomics Unit, University of Lausanne | Presenter Bio: Vera van der Velpen finished her BSc in Nutrition and Health and her MSc in Food Safety at Wageningen University before starting her PhD at the same university in 2009. In her PhD, she applied transcriptomics in two clinical trials to investigate the potential health effects of isoflavone supplementation in postmenopausal women. She moved on to the University of East Anglia in 2014 for her first PostDoc position, where she first applied mass spectrometry-driven metabolomics to measure exposure markers of blueberry consumption in a large clinical trial.
Since September 2017, she is working as a PostDoc at the University of Lausanne in the group of Julijana Ivanisevic, where she is using metabolomics to study the changes in brain metabolism in Alzheimer’s disease.
No relevant financial relationship(s) to disclose.
|
|